Gerrit Dispersyn
2018
In 2018, Gerrit Dispersyn earned a total compensation of $425K as President and Chief Executive Officer at RXi Pharmaceuticals, a 84% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $52,800 |
|---|---|
| Option Awards | $27,504 |
| Salary | $315,558 |
| Stock Awards | $28,640 |
| Other | $454 |
| Total | $424,956 |
Dispersyn received $315.6K in salary, accounting for 74% of the total pay in 2018.
Dispersyn also received $52.8K in non-equity incentive plan, $27.5K in option awards, $28.6K in stock awards and $454 in other compensation.
Rankings
In 2018, Gerrit Dispersyn's compensation ranked 12,365th out of 14,244 executives tracked by ExecPay. In other words, Dispersyn earned more than 13.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,365 out of 14,244 | 13th |
Division Manufacturing | 5,009 out of 5,765 | 13th |
Major group Chemicals And Allied Products | 1,896 out of 2,128 | 11th |
Industry group Drugs | 1,623 out of 1,817 | 11th |
Industry Pharmaceutical Preparations | 1,243 out of 1,391 | 11th |
Source: SEC filing on August 30, 2019.
Dispersyn's colleagues
We found one more compensation record of an executive who worked with Gerrit Dispersyn at RXi Pharmaceuticals in 2018.
2018
Geert Cauwenbergh
RXi Pharmaceuticals